H. Tiddens (Rotterdam, Netherlands), J. Bhatt (Nottingham, United Kingdom)
Late-breaking abstract: VX-770, an investigational CFTR potentiator, in subjects with CF and the G551D mutation B. J. Plant, B. Ramsey, K. Yen, Q. Dong, S. Rodriguez, J. S. Elborn (Cork, Ireland; Seattle, Cambridge, United States Of America; Belfast, United Kingdom)
| |
Improvement in lung function during the 1st year of life in infants diagnosed with CF through newborn screening (NBS) L. Thia, A. F. Hoo, T. D. Nguyen, D. Ahmed, S. Lum, J. Chudleigh, C. Wallis, A. Bush, A. Wade, J. Stocks (London, United Kingdom)
| |
Infection and inflammation does not effect ventilation distribution in infants with cystic fibrosis (CF) S. J. Simpson, K. M. Logie, S. Schulzke, J. Park, S. Ranganathan, S. M. Stick, G. L. Hall (Perth, Melbourne, Australia; Basel, Switzerland)
| |
Comparison of cystic fibrosis structural lung disease detected by inspiratory and expiratory chest CT scans in infants and preschool children L. Mott, K. Gonzalez-Graniel, C. Murray, H. Tiddens, S. Stick, on Behalf of AREST CF (Perth, Australia; Rotterdam, Netherlands)
| |
Magnetic resonance imaging (MRI) as a non-invasive, radiation-free imaging modality to study the onset and progression of lung disease in infants and young children with cystic fibrosis M. Eichinger, E. Fritzsching, A. Kopp-Schneider, M. Sumkauskaite, D. E. Optazaite, M. Mall, M. Puderbach (Heidelberg, Germany)
| |
What is the significance of aspergillus fumigatus in BAL in children with cystic fibrosis R. Thursfield, A. Bush, A. Adams, A. G. Nicholson, K. Holden (London, United Kingdom)
| |
Newborn screening for cystic fibrosis improves lung function and growth at time of transfer to adult care N. Dijk, K. McKay, F. Barzi, D. Fitzgerald (Sydney, Australia)
| |